About
Gemphire Therapeutics is a biopharmaceutical company focused on developing treatments for Painful Diabetic Neuropathy (PDN) and Alzheimer's disease, notably after merging with NeuroBo Pharmaceuticals in 2019.
Explore Gemphire Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.